Carcinogenic susceptibility of rasH2 mice to troglitazone. 2007

Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo, 183-8509, Japan. meilan@cc.tuat.ac.jp

To evaluate the carcinogenicity of troglitazone in rasH2 mice, 7-week-old male and female rasH2 mice were fed a diet containing 0, 3,000 or 6,000 ppm troglitazone for 26 weeks. An increased tendency in the incidence of vascular tumors was observed in females of the 6,000 ppm group. The preliminary analysis using a high-density oligonucleotide microarray on a splenic hemangiosarcoma of a high dose female that could be obtained as a fresh sample showed that several genes related to the ras/MAPK pathway activation, angiogenesis, cell cycle and cell multiplication were up-regulated. In addition, most of the genes up-regulated were confirmed by the reverse transcriptase-polymerase chain reaction (RT-PCR). These results may suggest that the carcinogenic susceptibility of rasH2 mice to troglitazone is relatively low and up-regulations of the ras/MAPK pathway and angiogenesis-related genes are probably involved in the production of splenic hemangiosarcomas in rasH2 mice given troglitazone.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011905 Genes, ras Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Ha-ras Genes,Ki-ras Genes,N-ras Genes,c-Ha-ras Genes,c-Ki-ras Genes,c-N-ras Genes,ras Genes,v-Ha-ras Genes,v-Ki-ras Genes,H-ras Genes,H-ras Oncogenes,Ha-ras Oncogenes,K-ras Genes,K-ras Oncogenes,Ki-ras Oncogenes,N-ras Oncogenes,c-H-ras Genes,c-H-ras Proto-Oncogenes,c-Ha-ras Proto-Oncogenes,c-K-ras Genes,c-K-ras Proto-Oncogenes,c-Ki-ras Proto-Oncogenes,c-N-ras Proto-Oncogenes,ras Oncogene,v-H-ras Genes,v-H-ras Oncogenes,v-Ha-ras Oncogenes,v-K-ras Genes,v-K-ras Oncogenes,v-Ki-ras Oncogenes,Gene, Ha-ras,Gene, Ki-ras,Gene, v-Ha-ras,Gene, v-Ki-ras,Genes, Ha-ras,Genes, Ki-ras,Genes, N-ras,Genes, v-Ha-ras,Genes, v-Ki-ras,H ras Genes,H ras Oncogenes,H-ras Gene,H-ras Oncogene,Ha ras Genes,Ha ras Oncogenes,Ha-ras Gene,Ha-ras Oncogene,K ras Genes,K ras Oncogenes,K-ras Gene,K-ras Oncogene,Ki ras Genes,Ki ras Oncogenes,Ki-ras Gene,Ki-ras Oncogene,N ras Genes,N ras Oncogenes,N-ras Gene,N-ras Oncogene,c H ras Genes,c H ras Proto Oncogenes,c Ha ras Genes,c Ha ras Proto Oncogenes,c K ras Genes,c K ras Proto Oncogenes,c Ki ras Genes,c Ki ras Proto Oncogenes,c N ras Genes,c N ras Proto Oncogenes,c-H-ras Gene,c-H-ras Proto-Oncogene,c-Ha-ras Gene,c-Ha-ras Proto-Oncogene,c-K-ras Gene,c-K-ras Proto-Oncogene,c-Ki-ras Gene,c-Ki-ras Proto-Oncogene,c-N-ras Gene,c-N-ras Proto-Oncogene,ras Gene,ras Oncogenes,v H ras Genes,v H ras Oncogenes,v Ha ras Genes,v Ha ras Oncogenes,v K ras Genes,v K ras Oncogenes,v Ki ras Genes,v Ki ras Oncogenes,v-H-ras Gene,v-H-ras Oncogene,v-Ha-ras Gene,v-Ha-ras Oncogene,v-K-ras Gene,v-K-ras Oncogene,v-Ki-ras Gene,v-Ki-ras Oncogene
D002001 Adipose Tissue, Brown A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids. Brown Fat,Hibernating Gland,Brown Adipose Tissue,Fat, Brown,Tissue, Brown Adipose
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006394 Hemangiosarcoma A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed) Angiosarcoma,Angiosarcomas,Hemangiosarcomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
February 2009, Archives of toxicology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
January 2004, Toxicologic pathology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
October 2001, Journal of cancer research and clinical oncology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
October 2008, The Journal of toxicological sciences,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
December 2003, The Journal of toxicological sciences,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
October 2008, Archives of toxicology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
January 2013, Toxicologic pathology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
January 2005, International journal of toxicology,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
October 1999, Cancer letters,
Meilan Jin, and Miwa Takahashi, and Mitsuyoshi Moto, and Masako Muguruma, and Kazumi Ito, and Kyoko Watanabe, and Yusuke Kenmochi, and Taichi Kono, and Keiji Hasumi, and Kunitoshi Mitsumori
May 2000, Cancer letters,
Copied contents to your clipboard!